Daniel R. Hart - Jan 3, 2022 Form 4 Insider Report for Avid Bioservices, Inc. (CDMO)

Role
Chief Financial Officer
Signature
/s/ Daniel R. Hart
Stock symbol
CDMO
Transactions as of
Jan 3, 2022
Transactions value $
-$11,705
Form type
4
Date filed
1/5/2022, 06:54 PM
Previous filing
Jan 4, 2022
Next filing
Jan 11, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDMO Common Stock, $0.001 par value Options Exercise $2.83K +500 +1.83% $5.66 27.8K Jan 3, 2022 Direct F1
transaction CDMO Common Stock, $0.001 par value Sale -$14.5K -500 -1.8% $29.07 27.3K Jan 3, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CDMO Stock Option (right to buy) Options Exercise $0 -500 -0.21% $0.00 232K Jan 3, 2022 Common Stock 500 $5.66 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 15, 2021.
F2 Stock option granted to the reporting person on August 1, 2018, vests in four (4) equal annual installments beginning August 1, 2019 and each year thereafter until fully-vested, subject to the reporting person's continuous service to the Issuer on such vesting dates.